Anrukinzumab (Anti-IL-13)
Product Specifications
CAS Number
910649-32-0
Synonyms
IMA-638
Target
IL Receptor
Applications
Immunology & Inflammation
Additionnal Information
Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740276-500 1x 500 µL
TAG-72 / CA72.4 (B72.3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940026-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC550155-100 1x 100 µL
CD19 (CVID3/155), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682659-100 1x 100 µL
Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker) (KRT13/2213), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 